ZBNA
BIO icon

Zions Bancorporation, National Association’s Bio-Rad Laboratories Class A BIO Stock Holding History

Zions Bancorporation, National Association’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35K Sell
8
-2
-20% -$567 ﹤0.01% 1266
2026
Q1 		$2.79K Buy
+10
New +$2.88K ﹤0.01% 1127

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
AL
Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

Zions Bancorporation, National Association's BIO Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Bio-Rad Laboratories Class A (BIO) stake by 20% in Q2 2026, selling an estimated $567 and leaving 8 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Zions Bancorporation, National Association first reported a position in BIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.79K in Q1 2026. 167 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Zions Bancorporation, National Association held 8 shares of Bio-Rad Laboratories Class A worth $2.35K as of Q2 2026.
  • Zions Bancorporation, National Association sold 2 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $567.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1266 holding.
  • Zions Bancorporation, National Association first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and has held it in 2 quarters since.
  • Zions Bancorporation, National Association's Bio-Rad Laboratories Class A position peaked at $2.79K in Q1 2026.
  • 167 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.